title: Equine adipose-tissue derived mesenchymal stem cells and platelet concentrates: their association in vitro and in vivo.
abstract: Equine mesenchymal stem cells (MSC) are of particular interest both for basic research and for the therapeutic approach to musculoskeletal diseases in the horse. Their multilineage differentiation potential gives them the capability to contribute to the repair of tendon, ligament and bone damage. MSCs are also considered a promising therapeutic aid in allogeneic cell transplantation, since they show low immunogenicity and immunomodulating functions.Adipose tissue-derived adult equine stem cells (AdMSC) can be isolated, expanded in vitro and then inoculated into the damaged tissue, eventually in the presence of a biological scaffold. Here we report our preliminary experience with adipose-derived mesenchymal stem cells in allogeneic cell-therapy of tendonitis in the horse. MSCs, derived from visceral adipose tissue, were grown in the presence of autologous platelet lysate and characterized for their differentiation and growth potential. Expanded AdMSC were inoculated into the damaged tendon after their dispersion in activated platelet-rich plasma (PRP), a biological scaffold that plays an important role in maintaining cells in defect sites and contributes to tissue healing. Fourteen out of sixteen treated horses showed a functional recovery and were able to return to their normal activity.
authors.affiliation: Department of Animal Health, Veterinary Biotechnology, Food Quality and Safety, University of Parma, via del Taglio 8, Parma 43100, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Del Bue
authors.forename: S
authors.initials: S
authors.lastname: Riccò
authors.forename: R
authors.initials: R
authors.lastname: Ramoni
authors.forename: V
authors.initials: V
authors.lastname: Conti
authors.forename: G
authors.initials: G
authors.lastname: Gnudi
authors.forename: S
authors.initials: S
authors.lastname: Grolli
mesh_terms: D000273:Adipose Tissue / Q000166:cytology* / Q000502:physiology*; D000818:Animals; D017690:Cell Transplantation / Q000379:methods* / Q000662:veterinary; D006734:Horse Diseases / Q000601:surgery*; D006736:Horses / Q000097:blood / Q000502:physiology*; D045164:Mesenchymal Stem Cell Transplantation / Q000379:methods* / Q000662:veterinary; D059630:Mesenchymal Stem Cells / Q000166:cytology* / Q000502:physiology*; D010976:Platelet Count; D053657:Platelet-Rich Plasma; D052256:Tendinopathy / Q000601:surgery / Q000662:veterinary*; D023822:Tissue Engineering / Q000379:methods / Q000662:veterinary; D014184:Transplantation, Homologous; D016896:Treatment Outcome